Polycystic ovary syndrome risk factors

Jump to: navigation, search

Polycystic ovary syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic ovary syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycystic ovary syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic ovary syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic ovary syndrome risk factors

CDC on Polycystic ovary syndrome risk factors

Polycystic ovary syndrome risk factors in the news

Blogs on Polycystic ovary syndrome risk factors

Directions to Hospitals Treating Polycystic ovary syndrome

Risk calculators and risk factors for Polycystic ovary syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of Polycystic ovary syndrome are hyperinsulinemia secondary to insulin resistance, obesity, family history of PCOS among first-degree relatives, premature adrenarche, fetal androgen exposure, and low birth weight.

Risk Factors

Common risk factors in the development of Polycystic ovary syndrome are:

References

  1. Sortino MA, Salomone S, Carruba MO, Drago F (2017). "Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols". Front Pharmacol. 8: 341. doi:10.3389/fphar.2017.00341. PMC 5463048. PMID 28642705.
  2. 2.0 2.1 Morford JJ, Wu S, Mauvais-Jarvis F (2017). "The impact of androgen actions in neurons on metabolic health and disease". Mol. Cell. Endocrinol. doi:10.1016/j.mce.2017.09.001. PMID 28882554.
  3. Morford J, Mauvais-Jarvis F (2016). "Sex differences in the effects of androgens acting in the central nervous system on metabolism". Dialogues Clin Neurosci. 18 (4): 415–424. PMC 5286727. PMID 28179813.



Linked-in.jpg